IMR Press / EJGO / Volume 6 / Issue 2 / pii/1985035

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Radio-chemotherapeutic management of bone diffusion from breast carcinoma

Show Less
1 Institute of Radiology, University of Siena, Italy
2 Division of Medicine II, Hospital of Grosseto, Italy
3 Institute of Surgical Pathology, University of Siena, Italy
Eur. J. Gynaecol. Oncol. 1985, 6(2), 150–153;
Published: 10 June 1985

A combined modality therapy (irradiation p!us low-dose Adriamycin and Cyclo­phosphamide) was delivered to 41 patient affected by extensive bone diffusion from breast carci­noma. A 36% (15/41) objective response rate was obtained, no change was also detectable in 36%, while progressive disease in 28% (11/41). A subjective response was achieved in 37/41 pattients, i.e. .90%. The Authors remark the difficulties in evaluating the objective response of metastatic bone to therapy and confirm the keystone role of radiation therapy in the palliative treatment of breast cancer skeletal diffusion. 

Breast carcinoma
Bone diffusion
Back to top